XRP ETF News: 21Shares Moves TOXR to FTSE Pricing as Assets Near $150M
21Shares changed the pricing benchmark for its XRP ETF, TOXR, to the FTSE XRP Index from the CME CF XRP-Dollar Reference Rate. The fund has $149.7M in assets and the change takes effect Aug. 27. The move aligns TOXR with other 21Shares products and is expected to have no material impact on its operations or valuation.
How this was made
The 30-second read
Why it matters
Operational change with minimal immediate market impact but may improve pricing transparency.
Market read
The benchmark switch is a modest, procedural update for XRP ETFs, offering slight operational benefits without altering fundamental demand.
What to watch
Potential impact on ETF tracking error and liquidity for large institutional orders.
Background
21Shares' TOXR ETF provides direct exposure to XRP; benchmark change aligns with other 21Shares products.
Ticker impact
21Shares switched the TOXR ETF pricing benchmark from CME to FTSE, a new operational change affecting XRP exposure pricing.
Limited short-term price movement; may improve institutional comfort.
Benchmark change is operational, not a fundamental shift in XRP demand.
Market effects
May encourage more institutional adoption of spot crypto ETFs.
U.S. crypto ETF market sees procedural alignment with other products.
Limited; primarily affects U.S. ETF investors.
Counterpoint
Benchmark shift unlikely to move XRP price; focus remains on broader crypto market dynamics.
Key entities
- company21Shares
Issuer of the TOXR XRP ETF.
- companyAnchorage Digital
Custodian for the ETF's XRP holdings.
